Research Grant, Patent Grant

RNS Number : 6897M

Byotrol PLC

28 May 2010

 



28 May 2010

Byotrol plc

Award of Research Grant, Enhanced Patent Grant

and

Directorate Change

Byotrol plc ('Byotrol' or 'the Company'), the leading AIM listed anti-microbial hygiene company, is pleased to announce that it has been awarded a research grant by North West Development Agency (NWDA) to assist in funding the development of an innovative bio-medical product.  The NWDA grant, totalling £443,824, is to be paid over three years to develop, in particular, the range of applications in the Consumer Products division.

NWDA innovation grants are only awarded to proven technologies which have undergone rigorous testing.

In addition to the research grant announced above, the UK Patent Office has granted a further technology patent as of June 16th 2010 in favour of the Byotrol anti-microbial technology.  This patent, which builds on the original international Byotrol patent protection, covers key ingredients responsible for the molecular structures that are now known to provide Byotrol with its leading edge anti-microbial residual efficacy.  Granting of this patent extends the scope of the original patent and helps to build the Byotrol anti-microbial technology platform.

Byotrol also announces that, due to his taking up the Cabinet post of Secretary of State for the department of Work and Pensions in the Coalition Government, Iain Duncan Smith has resigned as a Director of the Company.

Mr Duncan Smith was not remunerated in his advisory role at Byotrol.  The Board wishes him well in his new post and thanks him for his support and advice over the last twelve months.

Commenting on the award, Dr Gary Millar, CEO of Byotrol said:

"We are very excited and proud to have been awarded an exceptional R&D grant by the Northwest Regional Development Agency. The confidence of NWDA in both our technology and our ambition to develop new anti-microbial products aimed at the Healthcare, Foods and Consumer sectors is a significant endorsement.

"The grant will help Byotrol to grow its technical resources at our laboratory at Daresbury Science and Innovation Campus and build good science around anti-microbial technology in a challenging and very topical market."

Enquiries:

Byotrol plc                                                                                              0161 277 9518

Gary Millar, Chief Executive

Richard Bell, Finance Director

Charles Stanley Securities                                                                        020 7149 6000

Nominated Adviser

Russell Cook / Carl Holmes

Winningtons                                                                                             020 3043 4162

Tom Cooper / Paul Vann                                                                         0797 1221972

Notes to Editors:

Byotrol Plc (BYOT.L), quoted on AIM, is a leading microbial technology hygiene company, operating globally in the Health, Food, Leisure, Consumer, Industrial and Agriculture sectors, providing a low toxicity product with a broad-based and long lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, microbacteria and algae.

The Byotrol product can be used as a stand alone product or as a complementary biocide additive to existing products to improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

Founded in 2005, the Company has prioritised the development of a technology that creates easier, safer and cleaner lives through partnering with providers of essential goods and services.  Byotrol is the catalyst behind the aptly named global 'Hygiene Revolution'.

 

END

 

 

MSCARMFTMBITBPM